Sedation. Failed moderate sedation during procedure
Conditions
Interventions
Intervention 1: Intervention group: Chloral hydrate will be administered orally. Children in this group will receive 5% chloral hydrate syrup at a dose of 50-100 micrograms/kg orally 10 minutes before
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
6 Months to 10 Years
Inclusion criteria
Inclusion criteria: Children who are candidates for MRI and require sedation for any reason. The child's parents must consent to participate in the study.
Exclusion criteria
Exclusion criteria: Patients with a history of respiratory diseases Stomach ulcers or liver disease Treatment with drugs that interact with chloral hydrate or dexmedetomidine The presence of a specific underlying condition that affects the interpretation of goals such as duration of sedation Any previous allergic reaction to chloral hydrate or dexmedetomidine
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sedation. Timepoint: Patients were examined every 5 minutes and then every 10 minutes for up to an hour. Method of measurement: The AVPU scale is used to assess a child's level of alertness and sleepiness. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohamadreza Ghazavi
Esfahan University of Medical Sciences
Outcome results
None listed